Monsanto Licenses Broad Institute CRISPR/Cas9 Technology

05:44 EDT 23 Sep 2016 | Genetic Engineering News

Monsanto said it has signed a nonexclusive global license with the Broad Institute of MIT and Harvard for agricultural applications of its CRISPR/Cas genome-editing technology.

The value of the agreement and other terms were not disclosed.

Monsanto—which is being acquired by Bayer for $66 billion—and the Broad Institute said the agreement is expected to be applied toward improved crops.

“Genome-editing technologies, such as CRISPR/Cas, offer a way for scientists to promote site-directed integration of specific genes as well as the opportunity to enhance beneficial or remove undesired plant characteristics. These techniques will enable plant breeders to deliver better hybrids and varieties more efficiently,” Monsanto said in a statement.

The license “provides access to an exciting tool for our growing body of genome-editin

Original Article: Monsanto Licenses Broad Institute CRISPR/Cas9 Technology


More From BioPortfolio on "Monsanto Licenses Broad Institute CRISPR/Cas9 Technology"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

GMO Crops
A genetically modified organism (GMO) is an organism whose genetic material has been altered using genetic engineering techniques. Organisms that have been genetically modified include micro-organisms such as bacteria and yeast, insects, plants, fish, an...